NORTECH SYSTEMS INC - 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 1998, and the nine-month period ended on the same date. NorTech Systems Inc. is a Minnesota-based corporation engaged in the manufacturing of medical equipment, specifically monitoring systems.
Key Financial Metrics
| Metric | Q3 1998 (3 Months) | Q3 1997 (3 Months) | YTD 1998 (9 Months) | YTD 1997 (9 Months) |
|---|---|---|---|---|
| Revenue | $9,625,049 | $8,693,449 | $29,699,618 | $26,297,471 |
| Gross Profit | $1,735,116 | $1,564,735 | $5,264,357 | $4,740,540 |
| Gross Margin | 18.0% | 18.0% | 17.7% | 18.0% |
| Net Income | $126,719 | $140,555 | $560,989 | $440,563 |
| Diluted EPS | $0.05 | $0.06 | $0.24 | $0.19 |
| Cash & Equivalents | $288,609 (as of Sept 30, 1998) | |||
| Working Capital | $11,076,079 (as of Sept 30, 1998) | |||
| Total Debt | $11,609,405 (Current: $1.49M; Long-term: $10.62M) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 10.7% year-over-year for the quarter and 13.0% for the nine-month period, driven primarily by internal growth.
- Profitability: While revenue grew, quarterly net income decreased 9.8% ($126,719 vs. $140,555) due to increased engineering and development costs for the new "autosync monitor." However, year-to-date net income increased 27.3%.
- Cash Flow: Operating activities consumed $377,995 in cash for the nine months ended Sept 30, 1998, compared to $221,917 in the prior year. This was largely due to a $1.4 million increase in inventory levels.
- Liquidity: Working capital improved significantly from $9.67 million at year-end 1997 to $11.08 million in Q3 1998, despite a decrease in cash on hand from $714,169 to $288,609.
Outlook, Risks, and Management Commentary
- Guidance: Management anticipates fourth-quarter 1998 revenue levels to be slightly higher than the third quarter.
- Backlog: The 90-day order backlog stood at $8,207,000 as of September 30, 1998, a slight increase from $8,159,000 at the start of the quarter.
- Liquidity Outlook: The company expects financial stability to improve and believes operating cash flow and available credit facilities are sufficient to fund near-term growth.
- Risks/Contingencies: The filing does not explicitly detail specific legal contingencies or unusual items beyond the noted increase in R&D expenses for new product development.
Investor Verification Checklist
- Verify the sustainability of the 13% year-over-year revenue growth rate.
- Confirm the timeline and commercial viability of the new "autosync monitor" to ensure R&D costs translate to future margins.
- Monitor inventory levels, which increased by $1.4 million year-to-date, to ensure they align with the $8.2 million order backlog.
- Review the company's ability to service $11.6 million in total debt given the negative operating cash flow for the nine-month period.